Nearly four decades ago, Francis Young, chief administrative law judge at the Drug Enforcement Administration (DEA), concluded that marijuana did not belong in Schedule I of the Controlled Substances ...

The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say.

President Donald Trump signed an executive order Thursday that could reclassify marijuana as a less dangerous drug and open new avenues for medical research, a major shift in federal drug policy that ...

The reclassification doesn't suddenly make pot legal in the U.S., but it does mark an important shift in the country's relationship with the drug.

The U.S. administration reclassified state-licensed or FDA approved marijuana products from a Schedule I to a Schedule III drug. This reclassification does not immediately change marijuana's legal ...

President Donald Trump confirmed earlier this week that he is weighing rescheduling marijuana—that is, moving the drug to a less-restrictive classification under federal law. State-legal marijuana ...

When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for ...

For years, marijuana has been classified as a Schedule I drug under the federal Controlled Substance Act. Heroin, LSD, peyote, and quaaludes are other drugs that fall under the Schedule I ...

Marijuana moved from Schedule I to Schedule III under a rule change by the Trump administration. That change will likely open ...

Sen. Tom Cotton (R-Ark.) on Thursday criticized the Department of Justice’s (DOJ) decision to downgrade state-approved medical marijuana to a less dangerous drug. “Marijuana today is much more potent ...